GSK-3 as potential target for therapeutic intervention in cancer - Test2 - elhamkhani - TriplyDB

GSK-3 as potential target for therapeutic intervention in cancer

GSK-3 as potential target for therapeutic intervention in cancer

http://www.wikidata.org/entity/Q27013811

about

Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging The PI3K/Akt Pathway in Tumors of Endocrine Tissues Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian Cancer Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.Role of Akt-independent mTORC1 and GSK3β signaling in sublethal NMDA-induced injury and the recovery of neuronal electrophysiology and survival Didymin: an orally active citrus flavonoid for targeting neuroblastoma.The interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancer.Neuroprotective Functions for the Histone Deacetylase SIRT6 Myeloid cell leukemia-1 is associated with tumor progression by inhibiting apoptosis and enhancing angiogenesis in colorectal cancer.Notch signaling regulates antigen sensitivity of naive CD4+ T cells by tuning co-stimulation.Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures.Proteomic insight into the molecular function of the vitreous Reverse-Phase Microarray Analysis Reveals Novel Targets in Lymph Nodes of Bacillus anthracis Spore-Challenged Mice.Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis.Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cells Genetics, diagnosis and management of colorectal cancer (Review).Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs.A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.α-Mangostin, a Natural Agent, Enhances the Response of NRAS Mutant Melanoma to Retinoic Acid.FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β.Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3α/β Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine Lithium Chloride Promotes Apoptosis in Human Leukemia NB4 Cells by Inhibiting Glycogen Synthase Kinase-3 Beta.Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)Combined application of arsenic trioxide and lithium chloride augments viability reduction and apoptosis induction in human rhabdomyosarcoma cell lines.Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.Glycogen synthase kinase-3: a potential preventive target for prostate cancer management Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis.Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2 Obg-like ATPase 1 regulates global protein serine/threonine phosphorylation in cancer cells by suppressing the GSK3β-inhibitor 2-PP1 positive feedback loop.The expression of presenilin 1 enhances carcinogenesis and metastasis in gastric cancer.Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/β-catenin signaling.Molecular Signaling in Benign Odontogenic Neoplasia Pathogenesis

P2860

Q26739711-EECEA752-48EB-49A6-86B4-E4A4925F990B Q26768475-C7A455A4-C3C3-4540-A18B-9E7CA2E58F85 Q26770404-EEE52F75-C5A5-4246-9CE5-87178CAE60F7 Q26798203-32005C92-F3BD-4ECD-9AED-9020AFCB65E1 Q27313653-17EE59DA-3F72-4015-9597-CB610A119A50 Q28072650-189EA865-6302-4954-84C9-87C494C75DFA Q28468466-8DD7C227-E0BA-4D0E-B921-820EB6DDDD8E Q28547446-80BFFA3D-C0A3-4B2A-A549-6395A39597AE Q28552533-13803A6D-E04F-4B07-BFF6-26BD9A798D49 Q28553513-C1E3B10C-4DB1-46C1-8916-D1E934B57407 Q30315106-64FC110B-ABD9-45DF-9643-8E5E3C3FC7DA Q33618479-0CC28EBD-79CA-4A68-A1D9-7DBA9E9E2EBB Q33685626-72F430AC-9D2E-48D8-9BA7-406D673C7ADF Q33710161-89B1B111-CC40-438E-BEB0-604DEE0A2B88 Q33768672-E3EE42AF-A9AC-47AD-AF18-47D05FFBEA3A Q34554358-562B5D84-AAB6-4587-990D-84479D2C5315 Q34991284-3A568DAA-8F7F-4ED1-959A-3C7A558E229F Q35041145-10BD1B3B-6DD3-495C-B148-B750A9619FC4 Q35247201-6C20F037-2FD0-46F4-9345-75A12E133308 Q35645169-0B3E1ED9-66B2-4C13-A72E-1FEFC8F2704B Q35668869-28476E92-920B-4FF0-BC8F-55828C847A5F Q35742439-E85AE4F4-406F-4307-B105-19ACF844F71D Q35832986-A555392B-25E6-4375-83E6-088B04245CC1 Q35934455-ED7927F1-3F49-459D-96A6-4548D5ECAC58 Q35948915-3267E123-DF85-4BB9-BA7A-376D88964931 Q35973676-FE635F0D-7214-40F5-A58C-6166924AF0AE Q35996844-E1EE82D4-24C0-4B65-A075-4F98697B528C Q36023053-47DA5027-5442-4597-83C8-88B124F0CE19 Q36048048-81EEEA26-07AC-4049-BAA3-8C2524FF2129 Q36189756-508BA846-45D2-4FB4-9436-03FC602C314E Q36280761-8BAB4745-78E7-479D-9A0E-8F4871CC531C Q36390944-D4F747DD-6F84-480E-81E0-29D057D9ACBC Q36544778-7E8DC7E3-174D-4D29-9217-63B2BE7FA6EF Q36580561-460297FF-7D24-4B83-A536-EEF460D6558B Q36606111-BF9D1778-0970-49B3-96CB-3E9099163B59 Q36619084-14A52652-183C-4238-8DA4-04602ACC1247 Q36772158-AD1E9DF6-4BED-4A3C-9F90-6A2BFC0A2F16 Q36963063-64D592AC-9BE2-48BB-93A7-2B7D6075544C Q37085942-DABE38ED-50A7-4559-8D1D-FD80DEDD0661 Q37183900-8E8403F6-47DE-4549-8D51-F0A79790C397

P2860

GSK-3 as potential target for therapeutic intervention in cancer

http://www.wikidata.org/entity/Q27013811

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

GSK-3 as potential target for therapeutic intervention in cancer

@ast

GSK-3 as potential target for therapeutic intervention in cancer

@en

GSK-3 as potential target for therapeutic intervention in cancer

@nl

type

label

GSK-3 as potential target for therapeutic intervention in cancer

@ast

GSK-3 as potential target for therapeutic intervention in cancer

@en

GSK-3 as potential target for therapeutic intervention in cancer

@nl

prefLabel

GSK-3 as potential target for therapeutic intervention in cancer

@ast

GSK-3 as potential target for therapeutic intervention in cancer

@en

GSK-3 as potential target for therapeutic intervention in cancer

@nl

P1433

Q27013811-ED387B6E-5542-4BF7-B532-D0811F4F5153

P1476

Q27013811-1AA267F1-F19F-428E-B424-90FA8EE51633

P2093

Q27013811-02B9F0DD-C66A-41B1-AA1D-F13F858BFD6F

Q27013811-032DB179-04FA-40EC-9DF6-89BE025A8AD9

Q27013811-04D49AF7-DAAB-4C98-9A7E-3400AA5C14A7

Q27013811-29AF21BE-1486-4407-8909-451DF2F3D7CB

Q27013811-38CE78A8-3312-4699-8651-3284BA037496

Q27013811-468A90F7-4F10-4EBF-B620-35D22D632662

Q27013811-79465584-9F24-47F9-8E5B-6CCFE211AB75

Q27013811-81A9B2B1-738A-4CD1-A4F4-3D8C2D524185

Q27013811-838E87FC-F29B-42C4-B158-B1B770771BAE

Q27013811-915E342C-2B56-4E13-87B9-210226BEC49A

P275

Q27013811-F0F1F648-B5E0-4F0D-8935-34092BEB270F

P2860

Q27013811-003B1DED-234B-452E-8700-2295B44C7134

Q27013811-01F035BD-DE2D-43A6-918C-9D80D7E5620B

Q27013811-027D77A4-995B-46CA-BED5-ED5C06A0BD8E

Q27013811-045FD6E5-1A44-4F80-9F46-CFF6295A6027

Q27013811-04C7EEBD-3501-4545-8887-044BA77BA622

Q27013811-0531EB00-413C-4256-A13E-42E7BAC71119

Q27013811-078A9FF9-4B5B-4661-B3BD-6EBDCED3D508

Q27013811-07D0640D-CECC-41F4-A851-58BE23BDDA57

Q27013811-08604D53-E7C9-436F-8F0D-10234010AFB2

Q27013811-09FCACAE-6CAC-4F46-80E3-FBA28B0E89D5

P304

Q27013811-085D9E0A-266A-42BD-9D74-C1FDD78C65BA

P31

Q27013811-24333743-6A36-4FD3-82D1-761204361EC5

Q27013811-E89ADA93-B976-4A47-A071-DE86C5712BFC

P3181

Q27013811-4F33A892-604F-4BF0-ADF7-AFA5EF2308BB

Q27013811-CCD5E8F7-F1DF-46F3-AD09-F2C191FAA98F

P356

Q27013811-6082DF83-302F-4701-B249-7E2F8F028648

P407

Q27013811-A10CE637-C11B-4CF5-A7D4-CE0052927CB6

P433

Q27013811-FCB76AC4-889F-4BFD-BEF5-E73839377AE6

P478

Q27013811-0CB94673-D2AB-4449-BD1F-B097A776E23F

P50

Q27013811-1587060C-DC1D-474F-979A-8A0C7E905ADD

Q27013811-61E8E3F9-F091-4C0B-9D45-3FF434139FE3

Q27013811-BDBA508E-FC30-4C5F-9C6D-F4D8E7A558A6

P5008

Q27013811-531C24AB-3205-4757-9351-5067A7B9C998

P577

Q27013811-32DF06D6-E611-4D8E-AF7E-04C97663C492

P5875

Q27013811-4E8CEEDA-79FE-48F0-B9B9-ECAC9BABE8D1

P698

Q27013811-E054EB33-7062-4B45-A972-3132C909312D

P921

Q27013811-420250C9-3FAE-4E98-9E34-2CD9C7E0D62F

Q27013811-80DDDABE-0C89-42DE-9D89-066321BA569D

Q27013811-8296A0C3-F819-4205-9C55-209336DC4DB0

Q27013811-B0488952-1761-4516-AFE6-B4CD3A209248

P932

Q27013811-D9FB5122-0BEB-4D33-97A0-E73D004EFBEF

P3181

P356

ONCOTARGET.2037

P1433

P1476

GSK-3 as potential target for therapeutic intervention in cancer

@en

P2093

Agnieszka Gizak

http://www.w3.org/2001/XMLSchema#string

Alberto M. Martelli

http://www.w3.org/2001/XMLSchema#string

Antonino B. D’Assoro

http://www.w3.org/2001/XMLSchema#string

Dariusz Rakus

http://www.w3.org/2001/XMLSchema#string

Ferdinando Nicoletti

http://www.w3.org/2001/XMLSchema#string

Fred E. Bertrand

http://www.w3.org/2001/XMLSchema#string

James A. McCubrey

http://www.w3.org/2001/XMLSchema#string

Linda S. Steelman

http://www.w3.org/2001/XMLSchema#string

Lucio Cocco

http://www.w3.org/2001/XMLSchema#string

Massimo Libra

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1

The role of glycogen synthase kinase 3 beta in the transformation of epidermal cells

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

A beta version of life: p110β takes center stage

PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR

Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal

GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl

Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity

Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta

A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells

P304

2881-911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2551411

http://www.w3.org/2001/XMLSchema#string

879767

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/ONCOTARGET.2037

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Montalto

Melchiorre Cervello

P5008

P577

2014-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263131158

http://www.w3.org/2001/XMLSchema#string

P698

24931005

http://www.w3.org/2001/XMLSchema#string

P921

macromolecular substances

P932

4102778

http://www.w3.org/2001/XMLSchema#string